T: +32 (0)474 98 86 68
DNV believes that biosafety and biosecurity (collectively known as biorisk) are closely interlinked, and that common systems are required to manage both effectively. Biosafety involves harm to people and other organisms whereas biosecurity covers the deliberate unauthorised removal of biological materials and its products.
Our approach
DNV has expertise in the area of biorisk (addressing biosafety and biosecurity), and has worked with a number of internationally recognised institutes and companies ranging from in conducting audits, design reviews and risk assessments of their biocontainment facilities.
Our biorisk team has not only have experience in assessing the physical requirements of the biorisks of biological containment, but also has expertise in assessing the laboratory biorisk management system within an organisation. At DNV, we place equal emphasis upon other organisation issues and ensuring the stakeholders are provided with an assurance that the organisation has taken and implemented reasonable measures and controls to reduce risks associated with biological agents.
Using a risk-based approach, our biorisk team can help your facility and organisation to identify risks and hazards derived from biological agents and their products. We believe this approach is a proactive and preventative risk management measures that not only ensure regulatory compliance, but also greatly reduce the risk of harm to people and the environment, whist improving business performance.
Laboratory commissioning & validation
Commissioning and validation provides assurance that all relevant measures in the specification have been incorporated into the finished facility.
BSL3 facility certification
A process whereby a laboratory is independently assessed and certified against criteria derived from the World Health Organisation Biosafety Manual. The approach reflects internationally recognised certification principles.
Contact
Gerelateerd links
Downloads
Actueel
Combating avian flu
Indonesia is now the country with the highest number of human fatalities caused by the H5N1 influenza virus, often referred to as ‘avian flu’. In an effort to tackle the deadly disease, the prestigious Eijkman Institute in Jakarta has built a new biosafety level 3 (BSL3) laboratory – with the help of DNV.
A Star in the making
The Agency for Science, Technology and Research (A*STAR) is leading the way in biomedical research – with the help of DNV.